FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Men’s MS support group opens up: VIDEO
























Women make up the majority of patients affected by Multiple Sclerosis, two-thirds, so it’s not often you hear from the men with MS. A men’s support group at the Mandell MS Center at St. Francis in Hartford talks about their challenges with living with a disorder that affects the central nervous system.
Read more »

Labels:


 

Wheelchair-using speakers at a national disability conference had to be CARRIED on stage because there was no wheelchair access while the disabled toilets were being used for storage



































Speaker Deborah Haygarth, who has multiple sclerosis, was forced to get out of her wheelchair and carried by two people on and off the stage

'I thought 'They're going to pull out a ramp, they obviously planned for this',' she told Daily Mail Australia.
Read more »

 

Multiple Sclerosis: Understanding and Communication Important







































The National Institutes of Health defines multiple sclerosis (MS) as "an unpredictable disease of the central nervous system.
Read more »

 

MS Patients Weigh In on Physician Conflicts of Interest in New Study































Multiple sclerosis (MS) is difficult enough for those who have it, causing damage to the nervous system, difficulty with movement, sensation, numbness, loss of vision and pain. People with MS rely on medications and the care of physicians to manage their symptoms and the progressions of the disease. But what happens when physicians entrusted to care for MS patients have conflicts of interest, due to connections with the pharmaceutical industry, such as possible perks provided by specific drug manufacturers? A new study focuses on how MS patients feel about physician conflicts of interest — and indicates that these types of relationships are in fact of concern to people with MS.
Read more »

Labels:


 

Physiological Factors Contributing to Mobility Loss Over 9 Years of Follow-Up—Results From the InCHIANTI Study: STUDY

Thursday

 

Curcumin and Multiple Sclerosis

























About five years ago I interviewed a young woman (let’s call her Rose) with multiple sclerosis who was managing the disease with natural remedies. One of those remedies was curcumin, a compound present in the curry spice called turmeric.
Read more »

 

Have researchers discovered the sound of the stars?





























Researchers from the University of Copenhagen are the first in the world to develop a secure way of measuring the important protein apo-M. This could prove relevant for research into diseases such as diabetes, arteriosclerosis and sclerosis.
Read more »

 

Low Dose Naltrexone Review for MS Reveals High Safety Profile, Mixed Results on Benefits in Multiple Studies



















One of the most widely disputed treatments for multiple sclerosis is low dose naltrexone (LDN). While a plethora of patient testimonies and anecdotal evidence suggest immense benefits of LDN for multiple sclerosis, many clinicians are wary due to the lack of FDA approval outside of treating heroin and alcohol addiction.
Read more »

 

Exercise may improve cognitive performance in people with relapsing-remitting multiple sclerosis: STUDY


























Cognitive impairment is a major debilitating feature of multiple sclerosis, and is estimated to occur in more than 50% of people living with MS at some point during the disease. These cognitive impairments can appear as difficulties with learning and memory, and deterioration of executive functions, such as planning or decision-making, focusing attention, multi-tasking, and problem-solving.
Read more »

Labels: ,


 

CXCL13 antibody for the treatment of autoimmune disorders: STUDY

Wednesday

 

Digmanns share 20 year experience with multiple sclerosis By Jacob Kahn


























Dan Digmann and his wife, Jennifer speak on behalf of National Multiple Sclerosis Awareness Month on March 17 UC Rotunda. They will speak about their personal journey in coping with and rising above Multiple Sclerosis.

Dan and Jennifer Digmann took Central Michigan University students and community members on a journey through their experience with multiple sclerosis Tuesday in the Bovee University Center, by asking the audience to imagine their life in 20 years.
Read more »

Labels:


 

Translational Medicine Consortium Grants $1.9 Million for MS Research



















The Strategic Pharma-Academic Research Consortium for Translational Medicine has awarded its first grants totaling more than $1.9 million to support research projects dedicated to autoimmune diseases. Among the recipients is researcher Yanjiao Zhou, Ph.D., who is leading a study at Washington University in St. Louis (WUSTL) focused on multiple sclerosis (MS), as announced in a press release.
Read more »

 

University of Cambridge's Alastair Compston wins 2015 John Dystel Prize for MS Research































Professor Alastair Compston


The American Academy of Neurology (AAN) and the National Multiple Sclerosis Society are awarding the 2015 John Dystel Prize for MS Research to Alastair Compston, MBBS, PhD, Professor of Neurology at the University of Cambridge.
Read more »

 

The Glycan Role in the Glycopeptide Immunogenicity Revealed by Atomistic Simulations and Spectroscopic Experiments on the Multiple Sclerosis Biomarker CSF114(Glc): STUDY

 

Immune parameters of patients treated with Nerventra (Laquinimod), a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study: STUDY

Tuesday

 

Being diagnosed with multiple sclerosis: VIDEO





















People are most often diagnosed with multiple sclerosis or MS between the ages of 20 and 40. Everyone reacts differently to diagnosis. In this video people with MS talk about how they responded to their diagnosis.
Story Source: The above story is based on materials provided by NHSCHOICES
Note: Materials may be edited for content and length

Labels:


 

Things you can do for World MS Day: VIDEO
























World MS Day 2015 is coming up on May 27, and the first newsletter was emailed out on Sunday, March 15 to get people to help out all over the world.
Read more »

Labels:


 

Faces of MS: Diagnosed at 17, North Bergen woman finds a way to stay positive: SLIDESHOW































Kellie and her team at one of the annual MS Walks in Manhattan. courtesy of Kellie Barker

"It can be meningitis, a brain tumor, Lyme Disease or MS."
Read more »

Labels: ,


 

Multiple Sclerosis Eye Care Center Commemorates 10 Year Anniversary



















The Multiple Sclerosis Eye Center for Analysis, Research and Education (MS Eye CARE) is celebrating 10 years of expert eye care in improving diagnosis and treatment of multiple sclerosis (MS). The Center is the result of a collaboration between the University Eye Institute at the University of Houston’s College of Optometry and the National Multiple Sclerosis Society.
Read more »

 

Walking Distance as a Predictor of Falls in People With Multiple Sclerosis: STUDY

Monday

 

New treatment for multiple sclerosis slows disease prog­ression, reduces relapses




















Lisa Kapps

A groundbreaking new treatment for multiple sclerosis is now available in the United States and is being used to treat patients in San Antonio.
Read more »

Labels:


 

Spinal Cord Protein Possible Drug Target for Multiple Sclerosis




























A spinal cord change has been discovered and could be a target for new multiple sclerosis (MS) medications, according to findings published in the Annals of Clinical and Translational Neurology.
Read more »

 

MS walk photo gallery: SLIDESHOW

 

Multiple Sclerosis Diagnosis and Treatment Explained by Doctor Kevin Most





















Everyone knows that nerves are the pathway for information to our brain, to muscles and to many other areas in the body. The nerves have a protective layer  that surrounds them. Think of an electric cable, it has rubber around it and in the middle is a metal that allows for the energy to flow from one point to another. We have the same thing with nerves in our body, they have a protective layer called Myelin.
Read more »

Labels:


 

A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort: STUDY

Sunday

 

Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?





























For a disease that affects 2.5 million people around the globe and more than 400,000 people in the United States, it's a shame that so little is known about multiple sclerosis despite the amount of money being put into research of the disease.
Read more »

Labels:


 

A New Multiple Sclerosis Treatment On The Horizon? Anti-Inflammatory Molecule May Halt Disease
















































A group of researchers from Walter and Eliza Hall Institute have developed a new potential drug-like molecule that is capable of halting inflammation in the progression of multiple sclerosis (MS), a debilitating disease that has no cure.
Read more »

 

Medical pot patients keep waiting as legal challenges further delay program: VIDEO






















Marla Levi


A year and a half after Illinois lawmakers voted to legalize medical marijuana, Marla Levi is still waiting.
Read more »

Labels: ,


 

Newfoundland and Labrador funds treatment with AUBAGIO™ for Relapsing Remitting Multiple Sclerosis






























Genzyme, a Sanofi company, announced today that the Newfoundland and Labrador Prescription Drug Program (NLPDP) has included AUBAGIO™ (teriflunomide) 14 mg on the provincial drug formulary as a first-line oral agent for people in the province living with relapsing remitting multiple sclerosis (RRMS).
Read more »

Labels:


 

Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate: STUDY

Saturday

 

Can Emotional Health Influence MS Treatment Outcomes?




























Emotional health is important when battling any illness, including multiple sclerosis (MS). Despite this, sometimes the benefits of emotional health are overlooked by healthcare providers. Excessive stress can lead to anxiety and depression, which increases hormones such as adrenalin and glucocorticoids that shut down the immune system. Glucocorticoids have well-known negative effects on the nervous system.
Read more »

 

Hypertension Medication Found to Offer Protective Effect Against Multiple Sclerosis Symptoms in Mice



























A new study recently published in the journal Nature Communications led by researchers at The University of Chicago revealed that a drug for hypertension has a protective effect against symptoms characteristic of multiple sclerosis (MS) in mouse models. The study is entitled “Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.”
Read more »

 

Ozone Therapy: Hope for Chronic Illnesses





























When patients come to Howard Robins, they have been sick for a long time, they’ve tried conventional treatments, and they are running out of hope. They come to him with chronic fatigue, lupus, herpes, Lyme disease, fibromyalgia, cancer, arthritis, multiple sclerosis, and more.
Read more »

 

Salt Lake Gallery Stroll: Art Access exploring MS and Alzheimer's in art






























The new exhibits at the Art Access Gallery — opening Friday, March 20, in coordination with this month's Salt Lake Gallery Stroll — are all about what's going on in the artists' heads. Or bodies.
Read more »

 

Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial: STUDY

Friday

 

Ann Romney to write book on multiple sclerosis battle

























Ann Romney (Jack Gruber, USA TODAY)

Ann Romney is writing a book about her experiences living with multiple sclerosis, with proceeds going to benefit the center for neurological diseases she helped launch.
Read more »

 

Britons prove their ancestry is diverse



























Yet again your ancestry is being challenged, as DNA investigations uncover not only the key to disease, but also the very history that brought you into being. European colonisation of much of the world means that cystic fibrosis or multiple sclerosis incidence is often down to their genes, even in other races. It is the historical influence that is absolutely fascinating in this paper, which carefully dissects the British genomes of around 1900 and produces the most unexpected results. After the UK, Spain will be next to reveal its secrets, revealing, no doubt, some interesting conclusions on their great empire-building in the Americas.
Read more »

 

Boston Home seeks to build additional units for its clients













A rendering shows a proposed new apartment building along Dorchester Avenue on the campus of The Boston Home. Image courtesy TBH

The Boston Home, which provides specialized clinical care and residential services for adults with progressive neurological diseases, primarily advanced multiple sclerosis (MS), wants to build an apartment building on its property at the intersection of Dorchester Avenue and Gallivan Boulevard that will serve a separate purpose: accommodate people with MS and other neurological disabilities and their families in transition from nursing facilities or in need of specialized housing.
Read more »

 

NEUROLOGY TIMES ADVANCES MULTIPLE SCLEROSIS EDUCATION













Companies mentioned in this article: UBM Medica US
Read more »

Labels:


 

Fear of Falling Is Associated with Recurrent Falls in People with Multiple Sclerosis: A Longitudinal Cohort Study: STUDY

Thursday

 

Grand Bend woman running on behalf of MS Society Sarnia-Lambton chapter


















































Kandis Hodgins (left) is planning to run 91 kilometres from Sarnia and through various Lambton County communities on July 11 in honour of her mother, Lori Hodgins, who has lived with Multiple Sclerosis for 20 years.
Read more »

 

Caldwell resident fighting battle with multiple sclerosis
































Tara Tortoriello and Eleni Christoforou


Eleni Christoforou, 32, hopes that a hematopoietic stem cell transplant (HSCT) will strike a decisive blow in her decade-long battle with multiple sclerosis (MS).
Read more »

Labels:


 

Research and Markets: Secondary Progressive Multiple Sclerosis (SPMS) Therapeutics Pipeline Review 2015 - 11 Companies & 15 Drug Profiles

























DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/x7ptjv/secondary) has announced the addition of the "Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015" report to their offering.
Read more »

 

Multiple Sclerosis Treatments Benefit From Discovery of New Inflammatory Molecule

























A newly discovered molecule could play a pivotal role in inflammatory diseases, including multiple sclerosis, according to researchers at Trinity College Dublin and the University of Queensland Australia.
Read more »

 

Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment

Wednesday

 

Living with multiple sclerosis: It’s the hidden symptoms of MS which have the most impact
















































Progressive MS is visible. But the symptoms which have the biggest effect cannot be seen. Many people with MS experience these ‘invisible symptoms’ with no perceptible sign to the outside world.
Read more »

Labels:


 

Veterans riding to raise money for MS Foundation: VIDEO
























Two local vets have spent their whole life serving others whether it be in the military or on the job.
Read more »

Labels:


 

Two Progressive MS Phase III Trials to be Presented at AAN Annual Meeting



















Myelin — the fatty substance that wraps around nerve cells — is lost in multiple sclerosis (MS). Is there any way to get it back or to stop the deterioration of myelin? Researchers at MedDay Pharmaceuticals think that their drug may provide the solution. Known as MD1003, the medication targets the process of forming myelin, called myelination. It may stop the disease from progressing.

Read more »

 

EMD Serono amends deal with Opexa for multiple sclerosis drug Tcelna




























Merck subsidiary EMD Serono has made changes to its agreement with Opexa Therapeutics to develop and commercialize its investigational compound Tcelna (imilecleucel-T) for the treatment of multiple sclerosis.
Read more »

 

Improvement in Fatigue during Tysabri (Natalizumab) Treatment is Linked to Improvement in Depression and Day-Time Sleepiness


Go to Older News